mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.002 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.003 |